Themis Medicare Statistics
Total Valuation
Themis Medicare has a market cap or net worth of INR 9.46 billion. The enterprise value is 10.37 billion.
| Market Cap | 9.46B |
| Enterprise Value | 10.37B |
Important Dates
The last earnings date was Thursday, November 5, 2026.
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | Sep 23, 2026 |
Share Statistics
| Current Share Class | 92.10M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +3.42% |
| Shares Change (QoQ) | -0.41% |
| Owned by Insiders (%) | 35.65% |
| Owned by Institutions (%) | 1.56% |
| Float | 49.55M |
Valuation Ratios
The trailing PE ratio is 24.42.
| PE Ratio | 24.42 |
| Forward PE | n/a |
| PS Ratio | 2.83 |
| PB Ratio | 2.35 |
| P/TBV Ratio | 2.35 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 25.74 |
| EV / Sales | 3.10 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.84, with a Debt / Equity ratio of 0.25.
| Current Ratio | 1.84 |
| Quick Ratio | 1.10 |
| Debt / Equity | 0.25 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -4.67 |
Financial Efficiency
Return on equity (ROE) is 0.29% and return on invested capital (ROIC) is -7.78%.
| Return on Equity (ROE) | 0.29% |
| Return on Assets (ROA) | -1.05% |
| Return on Invested Capital (ROIC) | -7.78% |
| Return on Capital Employed (ROCE) | -2.30% |
| Weighted Average Cost of Capital (WACC) | 7.95% |
| Revenue Per Employee | 2.47M |
| Profits Per Employee | 298,320 |
| Employee Count | 1,340 |
| Asset Turnover | 0.58 |
| Inventory Turnover | 1.60 |
Taxes
In the past 12 months, Themis Medicare has paid 146.15 million in taxes.
| Income Tax | 146.15M |
| Effective Tax Rate | 26.77% |
Stock Price Statistics
The stock price has decreased by -14.44% in the last 52 weeks. The beta is 0.67, so Themis Medicare's price volatility has been lower than the market average.
| Beta (5Y) | 0.67 |
| 52-Week Price Change | -14.44% |
| 50-Day Moving Average | 111.85 |
| 200-Day Moving Average | 100.93 |
| Relative Strength Index (RSI) | 48.67 |
| Average Volume (20 Days) | 53,609 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Themis Medicare had revenue of INR 3.32 billion and earned 399.75 million in profits. Earnings per share was 4.20.
| Revenue | 3.32B |
| Gross Profit | 1.97B |
| Operating Income | -522.56M |
| Pretax Income | 545.90M |
| Net Income | 399.75M |
| EBITDA | -418.37M |
| EBIT | -522.56M |
| Earnings Per Share (EPS) | 4.20 |
Balance Sheet
The company has 91.50 million in cash and 1.00 billion in debt, with a net cash position of -909.41 million.
| Cash & Cash Equivalents | 91.50M |
| Total Debt | 1.00B |
| Net Cash | -909.41M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 3.99B |
| Book Value Per Share | 43.06 |
| Working Capital | 1.39B |
Cash Flow
In the last 12 months, operating cash flow was -32.65 million and capital expenditures -48.71 million, giving a free cash flow of -81.36 million.
| Operating Cash Flow | -32.65M |
| Capital Expenditures | -48.71M |
| Depreciation & Amortization | 104.19M |
| Net Borrowing | 171.03M |
| Free Cash Flow | -81.36M |
| FCF Per Share | n/a |
Margins
Gross margin is 59.27%, with operating and profit margins of -15.76% and 12.05%.
| Gross Margin | 59.27% |
| Operating Margin | -15.76% |
| Pretax Margin | 16.46% |
| Profit Margin | 12.05% |
| EBITDA Margin | -12.62% |
| EBIT Margin | -15.76% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.50, which amounts to a dividend yield of 0.49%.
| Dividend Per Share | 0.50 |
| Dividend Yield | 0.49% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 11.92% |
| FCF Payout Ratio | n/a |
| Buyback Yield | -3.42% |
| Shareholder Yield | -2.93% |
| Earnings Yield | 4.10% |
| FCF Yield | -0.87% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside |
Stock Splits
The last stock split was on October 10, 2023. It was a forward split with a ratio of 10.
| Last Split Date | Oct 10, 2023 |
| Split Type | Forward |
| Split Ratio | 10 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |